Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Blood Specimen Collection × Plasma cell × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 12 Gastrointestinal 8 Thoracic 4 Sarcoma 4 Myeloid 4 Lymphoid 3 Gynecologic 3 Genitourinary 3 Dermatologic 3 Other hematologic neoplasm 2 CNS 2 Tumor-Agnostic 1 Plasma cell 1 Other solid neoplasm 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 65 Lenalidomide 41 daratumumab 37 Bortezomib 31 Cyclophosphamide 27 pomalidomide 22 Calcium Dobesilate 22 carfilzomib 20 Biopsy 18 Specimen Handling 17 fludarabine 16 Magnetic Resonance Spectroscopy 15 talquetamab 14 iberdomide 11 dexamethasone acetate 11 dexamethasone 21-phosphate 11 auricularum 11 selinexor 8 isatuximab 8 fludarabine phosphate 7 belantamab mafodotin 6 venetoclax 5 trametinib 5 tocilizumab 5 X-Rays 4 Whole-Body Irradiation 4 nirogacestat 3 elotuzumab 3 dabrafenib 3 Stem Cell Transplantation 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07342179 2026-02-18

CART I5M

Poitiers University Hospital

Phase NA Recruiting

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡